Agenda

Of the 3rd International Practical Research Conference: Hematology. Innovations. Clinical Practice.

Round table discussion: Current approaches to treatment of multiple myeloma.

July 29, 2021. Venue: conference hall,15 Chkalov str. (Marriott Hotel), Irkutsk.

11.00 – 11.30 – Registration.

11.30 – 11.40 – Opening of the conference. Introduction of the conference participants – Natalia O. Saraeva, Chief hematologist of the Ministry of Health of Irkutsk region, Professor of the Department of the clinical care if the Irkutsk State Medical University, Tamara S. Krupskaya, Vice-Rector for International and Foreign Student Relations, M.D., PhD, Head of the Childhood Diseases and Infections Department, Irkutsk State Medical University. 

11.40 –12.00 – Multiple myeloma. Innovative approaches to treatment. – Larissa P. Mendeleeva, Doctor of Medical Sciences, Professor, Head of the Department for Scientific and Educational Work, National Medical Research Center of Hematology (Moscow). Sponsor: JSC R-Farm. No “continuous medical education” points are granted.

12.00 – 12.40 – A new paradigm in treatment of multiple myeloma: use of monoclonal antibodies in the first-line therapy. – Maxim V. Soloviev, head Department of Intensive High-Dose Chemotherapy of Paraproteinemic Hemoblastoses, Candidate of Medical Sciences, National Medical Research Center of Hematology (Moscow). Sponsor: Janssen. No “continuous medical education” points are granted.

12.40 – 13.20 – Study of the BAH domain: A new approach to old epigenetic regulation of gene expression and oncogenesis. –Huitao Fan, MD, PhD, Professor NHC Key Laboratory of Cell Transplantation, Key Laboratory of Hepatosplenic Surgery of Ministry of Education Department of Critical Care Medicine, The First Affiliated Hospital, Harbin Medical University; Zhao Yanhong, MD, PhD, Docror of Hematology, The First Affiliated Hospital, Harbin Medical University, China. In partnership with Irkutsk State Medical University. Irkutsk State Medical University. No “continuous medical education” points are granted.

13.20 – 14.00 – Lunch break.

14.00 – 14.30 – Current approaches to treatment of double refractory multiple myeloma – Larissa P. Mendeleeva, Doctor of Medical Sciences, Professor, Head of the Department for Scientific and Educational Work, National Medical Research Center of Hematology (Moscow). Sponsor: JSC R-Farm. No “continuous medical education” points are granted.

14.30 – 15.10 – New possibilities in immunotherapy of refractory and recurrent multiple myeloma – Sergey V. Semochkin, Professor of the Department of Oncology, Hematology and Radiation Therapy, Pirogov Russian National Research Medical University, Ministry of Health of Russia (Moscow). Sponsor: Bristol Myers Squibb. No “continuous medical education” points are granted.

15.10 – 15.50 – Double autologous transplantation of stem cells in multiple myeloma cases: a single-center study – Hyeok Shim, M.D. Division of Hematology & Oncology, Department of Internal Medicine Wonkwang University School of Medicine & Hospital, Iksan, Korea. In partnership with Irkutsk State Medical University. No “continuous medical education” points are granted.

15.50 – 16.10 – Experience of using Ixazomib in treatment of multiple myeloma. – Natalia O. Saraeva, Chief hematologist of the Ministry of Health of Irkutsk region, Professor of the Department of the clinical care if the Irkutsk State Medical University (Irkutsk). Sponsor: Takeda. No “continuous medical education” points are granted.

16.10 – 16.50 – Psychiatric approach to malignant blood neoplasms in Korea – Jin Yong Jun, M.D. National center for mental health Director of mental health services division Ministry of health of South Korea. In partnership with Irkutsk State Medical University. No “continuous medical education” points are granted.

16.50 – 17.00 – Discussion.

Speakers

Larissa P. Mendeleeva,
 
Doctor of Medical Sciences, Professor, Head of the Department for Scientific and Educational Work, National Medical Research Center of Hematology, Moscow

Maxim V. Soloviev,
head Department of Intensive High-Dose Chemotherapy of Paraproteinemic Hemoblastoses, Candidate of Medical Sciences, National Medical Research Center of Hematology, Moscow

Larissa P. Mendeleeva,
 
Doctor of Medical Sciences, Professor, Head of the Department for Scientific and Educational Work, National Medical Research Center of Hematology, Moscow

Maxim V. Soloviev,
head Department of Intensive High-Dose Chemotherapy of Paraproteinemic Hemoblastoses, Candidate of Medical Sciences, National Medical Research Center of Hematology, Moscow

Sergey V. Semochkin,
Professor of the Department of Oncology, Hematology and Radiation Therapy, Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow

Natalia O. Saraeva,
Chief hematologist of the Ministry of Health of Irkutsk region, Professor of the Department of the clinical care if the Irkutsk State Medical University

Sergey V. Semochkin,
Professor of the Department of Oncology, Hematology and Radiation Therapy, Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow

Natalia O. Saraeva,
Chief hematologist of the Ministry of Health of Irkutsk region, Professor of the Department of the clinical care if the Irkutsk State Medical University

Huitao Fan,
MD, PhD,
Professor NHC Key Laboratory of Cell Transplantation, Key Laboratory of Hepatosplenic Surgery of Ministry of Education Department of Critical Care Medicine, The First Affiliated Hospital, Harbin Medical University

 Yanhong Zhao,
MD, PhD,
Docror of Hematology, The First Affiliated Hospital, Harbin Medical University, China  

Huitao Fan,
MD, PhD,
Professor NHC Key Laboratory of Cell Transplantation, Key Laboratory of Hepatosplenic Surgery of Ministry of Education Department of Critical Care Medicine, The First Affiliated Hospital, Harbin Medical University

 Yanhong Zhao,
MD, PhD,
Docror of Hematology, The First Affiliated Hospital, Harbin Medical University, China  

Hyeok Shim,
M.D. Division of Hematology & Oncology, Department of Internal Medicine Wonkwang University School of Medicine & Hospital, Iksan, Korea

Jin Yong Jun,
M.D. National center for mental health Director of mental health services division Ministry of health of South Korea

Hyeok Shim,
M.D. Division of Hematology & Oncology, Department of Internal Medicine Wonkwang University School of Medicine & Hospital, Iksan, Korea

Jin Yong Jun,
M.D. National center for mental health Director of mental health services division Ministry of health of South Korea